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Untargeted lipidomics using liquid 
chromatography-ion mobility-
mass spectrometry reveals novel 
triacylglycerides in human milk
Alexandra D. George1 ✉, Melvin c. L. Gay1, Mary e. Wlodek2, Robert D. trengove3, 
Kevin Murray4 & Donna t. Geddes1
Human milk provides the infant with the essential nutritive and non-nutritive factors required for 
health, growth and development. the human milk lipidome is complex, but comprises predominantly 
triacylglycerides. Historically, the fatty acid profile of the entire human milk lipidome has been 
investigated, and many relationships have been identified between infant health and fatty acids. 
Most of these fatty acids are, however, delivered to the infant as triacylglycerides. Using liquid 
chromatography-ion mobility-mass spectrometry, the objective of this study was to characterise 
the triacylglyceride profile of human milk and elucidate relationships between the triacylglyceride 
profile and infant outcomes in a cohort of 10 exclusively breastfeeding woman-infant dyads. 205 
triacylglycerides were identified, including 98 previously not reported in human milk. The dose of 
specific triacylglycerides differed in relation to infant health, such as lauric acid containing TAGs, which 
were delivered in significantly higher dose to healthy infants compared to unwell infants.
The lipids in human milk (HM) are vital to the infant, not only as the main source of energy for infant growth, but 
in their role in immunological interactions and serving as structural components of the infant neural and retinal 
systems1,2. The HM lipidome is complex, with lipids strategically packaged as milk fat globules (MFG). The MFG 
encapsulates triacylglycerides (TAGs) inside the core, making up 98–99% of the total HM lipidome, while the 
surrounding MFG membrane is composed of other more polar lipids such as cholesterol and phospholipids3. The 
total lipids are the most variable macronutrient of HM, with sample concentrations varying anywhere between 
approximately 2 and 100 g/L, increasing throughout a feed, changing throughout the day, and typically increasing 
throughout lactation4. Lipid variations are also reported between women, with maternal diet influencing the fatty 
acid (FA) composition of the lipidome, but not changing the total lipid content5,6. HM FA analysis has classically 
been carried out using gas chromatography with flame ionisation detection (GC-FID), leading to a wider under-
standing of the importance of HM lipids for the infant. Relationships have been identified between docosahex-
aenoic acid (DHA), arachidonic acid (AA), and infant cognitive function, as well as between palmitic acid and 
infant infection and health1,7. FA research using GC-FID, however, does not account for the lipid species from 
which the FA came (such as the TAG), nor does it consider the FA location on each lipid structure (such as the 
Sn-1, -2 or -3 position of the TAG glycerol backbone). The positioning of the FA on the TAG glycerol backbone 
is particularly important because after ingestion, pancreatic and bile salt stimulated lipases preferentially hydro-
lyse the FA ester bonds from the Sn-1 and Sn-3 positions, resulting in two free FA and one monoglyceride8. The 
functions of the free FA and monoglycerides are different and incorporation of the different FA within the TAG 
provides the infant with the optimal mixture of FA and monoglycerides9.
The TAG profile in milk of different mammalian species has more recently been investigated using liquid 
chromatography-mass spectrometry (LC-MS) instrumentation10. While these techniques are able to differen-
tiate the carbon numbers and/or formula of these TAG species, they are often limited by the number of TAGs 
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identified and studies typically ignore the FA positioning within the TAG. The use of Liquid Chromatography-Ion 
Mobility-Mass Spectrometry (LC-IM-MS), however, has the capacity to differentiate isomeric TAGs based on 
their structural arrangements (using collision cross section) and potentially identify more individual TAGs at 
once, as has been achieved for other lipid species11. Furthermore, tandem mass spectrometry allows identification 
of the fatty acid Sn-2 positioning on the glycerol backbone by interrogation of the size difference of fragment ion 
spectral peaks12. LC-IM-MS lipidomics has been proven with comprehensive TAG characterisation in brain tissue 
and plasma, as well as bovine milk, however it has not been applied to the HM research field13–15.
Here we report the application of an LC-IM-MS method, and the corresponding analytical workflow, for 
detailed HM TAG profiling. The aim was to achieve not only higher coverage of TAG species than previously 
achieved in HM, but also to locate the Sn-2 position FA for a better understanding of the delivery of FA from 
these TAGs to the infant. The potential of this method is demonstrated by comparing analysis of pre-feed and 
post-feed samples, and samples from different time points in the day, from a cohort of 10 healthy, exclusively 
breastfeeding women at 3 months lactation. In this study we aimed to focus on the TAG dose that the infant 
received by simultaneously measuring individual HM production. Our findings report that LC-IM-MS can pro-
vide new information into the lipid profile of HM and the discovery of novel HM TAGs.
Materials and Methods
Analytical reagents. All solvents and calibrants were purchased from Merck (Sydney, Australia): Methyl 
tert-butyl ether (HPLC grade), Methanol (HPLC grade), Acetonitrile (Supelco, LC-MS grade), Water (LC-MS 
grade), 2-propanol (LC-MS grade), Ammonium formate (LC-MS grade), Formic acid, Poly-DL-alanine, Leucine 
enkephalin (HPLC grade), and tripentadecanoin standard.
Human milk sampling and storage. Human milk samples from 10 healthy lactating women were col-
lected as part of a longitudinal study. Six milk samples of up to 2 mL were manually expressed by mothers into 
sterile vials at 3 months post-partum (Fig. 1). Pre- (i.e. immediately before feeding) and post- (i.e. immedi-
ately after feeding) feed samples were collected between the following times: 0600 and 0900 h, 1900 and 2200 h. 
Additional pre-feed samples from first and second breast of the feed were collected between 1300 and 1600 h. 
Samples were stored immediately at −20 °C for less than 48 hours before being transferred to the laboratory 
freezer for storage at −80 °C prior to analysis. Each sample underwent 1 freeze-thaw cycle. Informed written 
consent was obtained from all participants for this study. All research was performed in accordance with rele-
vant guidelines and regulations. This study was approved by The University of Western Australia Human Ethics 
Research Office, RA/4/20/4023.
complementary analysis and data collection. Infant and maternal anthropometric measurements, 
maternal milk production, and other background details such as maternal age and parity, and infant sex were 
collected. Health status was also reported; infant and mother were listed as ‘unwell’ if cold-like symptoms were 
reported at time of data collection, or ‘healthy’ if no cold-like symptoms were reported. Infant weight, length and 
head circumference were measured with Medela Electronic Baby Weigh Scales (Medela Inc., McHenry, IL, USA), 
Seca 416 Infantometer (Seca, Chino, CA, USA), and a tape measure, respectively. Maternal weight was measured 
using Seca electronic scales (Seca, Chino, CA, USA). Maternal height was self-reported then confirmed by meas-
uring tape against a wall. Infant milk intake was assessed by measuring the maternal 24-hour milk production, 
with infant weights taken before and after every feed at 3 months post-partum16.
Lipid extraction. Lipids were extracted from 100 µL HM using a single-phase liquid extraction method con-
sisting of 700 µL tert-butyl methyl ether:methanol (50:50 v/v), based on a previously published method17. The 
mixture was vortexed for 1 min followed by 20 min centrifugation at 4000 × g. 150 µL of the supernatant, contain-
ing extracted lipids, was removed and transferred into a liquid chromatography vial.
Liquid chromatography-ion mobility spectroscopy-mass spectrometry (Lc-iM-MS). Lipidome 
profiling of HM samples was carried out using LC-IM-MS instrumentation (ACQUITY UPLC with a SYNAPT 
Figure 1. Human milk and complementary data collection workflow at 3 months post-partum, indicating the 
samples (*) and volume intake used for infant dose calculations.
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G2-S IM-Quadrupole Time of Flight (QTOF) Mass Spectrometer (Waters Corporation, Milford, MA, USA)), 
optimised based on a previously published method14. The autosampler tray was set to 15 °C. Lipid extracts (2 µL 
injection volume) were separated by an HSS-T3 column (Waters 100 ×2.1 mm, 1.8 µm, 100 Å), kept at 45 °C. A 
binary solvent system of mobile phase A (acetonitrile:water (60:40, v/v)) and mobile phase B (isopropanol:ace-
tonitrile (90:10, v/v)) was used, both containing 10 mM ammonium formate and 0.1% formic acid. Separation 
was carried out with a flow rate of 400 µL/min, for a total of 22 min, with the following gradient: 0 min, 60% 
A; 0–2 min, 57% A; 2–2.1 min, 50% A; 2.1–12 min, 46% A; 12–12.1 min, 30% A; 12.1–18 min, 1% A; followed 
by 4 minutes of re-equilibration to 60% A. Ion mobility spectroscopy was carried out using nitrogen drift gas 
and was calibrated with poly-DL-alanine infusion. Untargeted QTOF-MSE mass accuracy was calibrated using 
leucine-enkephalin, every 30 s, and TAGs with mass ranges of m/z 100–1200 were acquired in positive electros-
pray ionisation mode, with a scan rate of 30 scan/s and collision energy ramp of 20 to 55 eV. Mass accuracy was 
checked using tripentadecanoin standard solution prior to sample analysis. All samples were analysed in a single 
batch, with pooled sample quality control (QC) at least every 10 samples.
post analytics. Lipid identification was performed on raw data from pooled QC samples. Acquired data was 
exported from MassLynx version 4.1 (Waters Corporation, Milford, MA, USA) to DriftScope version 2.7 (Waters 
Corporation, Milford, MA, USA) for calibration. Calibrated data was then exported as a csv file, and analysed 
using Python scripts produced by Blazenovic et al.13, altered to search only m/z of [NH4]+ adduct ions and CCS 
for identification. Each result was confirmed in LipidCCS predictor and fragment ions were manually checked 
against LipidMaps predicted fragments18,19. FA positioning on glycerol backbone was tentatively identified by 
checking the mass spectra fragmentation patterns, whereby the Sn-2 fatty acid was identified from the spectral 
peak with the lowest intensity12. Results were compiled to produce an initial TAG list containing RT, m/z and 
CCS value for each identified TAG. Solvent blanks and pooled QC samples were used for validation. All pooled 
QC samples were analysed against the initial TAG list, the relative abundance was compared, and TAGs were 
removed if they were not identified in all QC samples, and/or if the CoV was above 25%, producing our in-house 
HM TAG list. To assess the TAG profile of the cohort samples, the raw data for each sample was calibrated in 
Driftscope and the resulting peak list was exported as a CSV file. These were searched against the HM TAG list 
using in-house R code (RStudio 2018 v3.5.2), with identification based on RT, m/z, and CCS (see Supplementary 
Material). Parameters of ± 1% error for CCS, ±0.02 Da difference for m/z, and ±0.15 min difference for RT were 
used. TAGs below the limit of detection (250 counts) were considered not present. Identified TAGs were manually 
searched for in publications that include TAG analysis in human milk, to report if they have previously reported.
GraphPad Prism version 8.2.0 (GraphPad Software, Inc.) was used for statistical analysis. Infant daily milk 
volume was compared between male and female infants using unpaired t-test. Creamatocrit lipid percentages of 
samples were converted to concentrations using the following equation Total lipid concentration(grams/litre) = 
(creamatocrit(%) − 0.59/0.146)20. Total lipid concentration was compared through a feed (pre-feed vs. post-feed, 
for morning and evening feeds), throughout a day (pre-feed morning vs. noon vs. evening), and between breasts 
(first breast of feed vs. second breast of feed), using paired t-tests. The concentration of each TAG was calculated 
from the relative TAG abundance and the total lipid concentration. Variation between samples (different women 
and different time points) was compared using relative standard deviation. Mixed model with fixed factors of 
sampling time (morning vs. noon vs. evening) and sampling type (pre-feed vs. post-feed) and random effect of 
mother was used to examine the TAG concentrations. Total daily TAG intake was estimated by daily milk volume 
and 98% of the average daily lipid concentration (calculated by averaging the morning and evening, pre- and 
post-feed concentration, feeds). Daily TAG intake was compared between infants using repeated measures 1-way 
ANOVA (accounting for maternal effect) and unpaired t-tests were used to compare TAG dose and infant sex 
and infant health. Relationships between daily TAG intake, infant growth and development, and maternal factors, 
were investigated using linear regression. Outlier assessment was carried out for all analyses using the ROUT 
method in GraphPad Prism. Statistical significance was considered at p < 0.05, all reported p values are adjusted 
for multiplicity, using GraphPad Prism false positive adjustment.
Results
The LC-IM-MS method identified 205 human milk TAGs (Fig. 2a), from almost 30,000 features. These TAGs were 
identified based on the precursor and fragment mass (m/z), RT and CCS from our in-house HM TAG list (produced 
from pooled QC samples), and TAGs with the same m/z were able to be separated by their CCS values (Fig. 2b).
Supplementary Table 1 describes the characteristics of the 205 HM TAGs. Of the 205 TAGs identified, 98 have, 
to the best of our knowledge, not been previously identified in HM. In this study the Sn-2 fatty acid was tenta-
tively identified for 120 triacid TAGs using the MS/MS fragmentation patterns, but could not be determined for 
the remaining 85 diacid TAGs. Supplementary Fig. 1 shows the process of tentatively identifying the Sn-2 position 
FA, and the overlapping ions within one spectra. No monoacid TAGs were identified.
Ten healthy breastfeeding mothers of term infants provided 6 milk samples for analysis at 3 months 
post-partum ± 2 days (Table 1). All mothers were exclusively breastfeeding their infant, with one occasionally 
expressing pumped milk for bottle feeds. Prior to, and following this study, all infants were trending along their 
respective growth curves and ahead of target with developmental milestones. On the day of collection, 4 infants 
had cold-like symptoms (referred to as ‘unwell’) and 6 were symptomatically healthy (referred to as ‘healthy’). All 
mothers were symptomatically healthy.
Daily milk intake for each infant was estimated by 24-hour test weighing resulting in a mean 24-hour intake 
of 727 ± 137 mL/day (range: 543–894 mL/day) for this cohort. Male infants received 247 mL more milk (p < 0.01) 
than female infants [95% CI: 177.1, 316.7]. Expressed milk samples (n = 60) were analysed for total lipid content 
(Table 2). No significant relationships were identified between maternal factors and infant volume intake, or 
infant anthropometric measurements.
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The total lipid concentration increased significantly through both the morning (p < 0.01) [mean difference: 
37.35; 95% CI: 19.74, 54.95] and evening (p < 0.01) feeds [mean difference of 27.49; 95% CI: 13.54, 41.44]. The total 
lipid concentration of the morning feed was not significantly different to that in the evening feed (p = 0.79). The total 
lipid concentration was significantly different between morning and average noon samples (p = 0.03) [mean differ-
ence: 12.05; 95%CI: 3.58, 20.50], but not between breasts (p = 0.64). Mean daily lipid dose to the infant, estimated 
from lipid concentration and milk intake, was 28.0 ± 12.4 g/day (range: 15.1–56.7). The mean daily lipid intake was 
higher in healthy infants than in unwell infants (30 g/day compared to 25 g/day), and higher in male infants than 
female infants (31 g/day compared to 23 g/day), but not significantly different in either case (p = 0.50 and p = 0.30 
respectively). No significant relationships were identified between maternal factors and HM lipid concentrations.
concentration of tAGs in human milk. The concentration of each TAG varied widely between and 
within women (RSD for all 60 samples for all TAG concentrations ranged from 54.0% and 534.7%). Significant 
concentration changes occurred in 4 of the 205 TAGs throughout the day (Fig. 3).
Figure 2. (a) Ion mobilogram displaying 205 different TAGs identified in human milk, with m/z for 
each TAG against measured CCS value. (b) Separation of C59H106O6 TAGs, TAG50(17:0_/19:0/_20:4), 
TAG51(18:2_19:1_19:1) and TAG52(18:0_/18:4/_20:0) with m/z 928.8328, by different CCS value.
Maternal◊
Mean ± standard 
deviation Range
Age (years) 31.2 ± 2.5 27–34
BMI (kg/m2) 26.3 ± 5.6 20.5–39.4
Parity (total offspring) 2.0 ± 1.0 1.0–3.0
Infant◊
Weight for age (percentile) 46.8 ± 24.4 11.1–98.8
Weight for length (percentile) 50.4 ± 31.5 6.3–97.5
Length for age (percentile) 47.6 ± 24.3 15.9–89.0
Head circumference for age 
(percentile) 77.0 ± 21.1 32.4–98.1
Table 1. Maternal and infant anthropometrics at 3 months post-partum. ◊ n=10 mother-infant dyads.
Sample type◊
Mean ± standard 
deviation (g/L) Range
Morning, pre-feed 20.9 ± 9.7 8.3–40.5
Morning, post-feed 58.3 ± 32.1 22.5–132.6
Noon, pre-feed, first 
breast 31.3 ± 17.0 3.5–62.2
Noon, pre-feed, second 
breast 34.6 ± 15.9 15.1–64.8
Evening, pre-feed 24.2 ± 10.0 12.7–43.9
Evening, post-feed 51.6 ± 18.4 22.6–74.0
Table 2. Concentration of total lipids in human milk samples collected at 3 months post-partum at different 
time points from 10 study participants. ◊n=60 samples.
5Scientific RepoRtS |         (2020) 10:9255  | https://doi.org/10.1038/s41598-020-66235-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
There were significant differences between pre- and post-feed samples in both morning (Supplementary 
Table 2) and evening (Supplementary Table 3) feeds. 22 of the 205 TAGs changed significantly through the morn-
ing feed and 25 of the 205 TAGs changed significantly through the evening feed. No differences existed between 
breasts, nor in comparison of samples from first and second breast. Two specific TAGs did increase significantly 
between first and second breast, TAG180(12:0_/17:2/_15:1) and TAG199(12:0_14:_14:1) (p=0.01 and p < 0.01 
respectively). No relationships were identified between concentration and maternal BMI, age or parity. All sample 
concentrations and 95% confidence intervals are listed in Supplementary Table 4.
Dosage of tAGs from human milk. After considering milk intake and estimated TAG concentrations, the 
infant daily dose for each TAG (g/day) was calculated (Supplementary Table 4). The dose for each TAG varied 
widely between infants (RSD from 31% to 266%). The total dose of each TAG was assessed in relation to infant 
growth percentiles (weight for length, height for age and weight for age), using PCA and linear regression, with 
no identifiable relationships. There was no relationship between infant head circumference percentile and the 
total dose of DHA- and AA-containing TAGs, both separate, combined and as a ratio. The total dose of eicosapen-
taenoic acid (20:5), myristic acid (14:0), and oleic acid (18:1)-containing TAGs were not related to infant growth 
percentile. However, the dose of all palmitic acid-containing (16:0) TAGs and all lauric acid-containing (12:0) 
TAGs were significantly different between healthy and unwell infants, typically delivered in higher dose to the 
healthy infant (Fig. 4) (p < 0.01). The dose of linoleic acid-containing (18:2) TAGs was higher in healthy infants 
than in unwell infants, although not significant (p = 0.15).
The average dose of TAG93(17:0_/13:0/_22:1), TAG193(12:0_12:0_18:3), and TAG199 (12:0_14:1_14:1) 
were higher in healthy infants and expressed the largest difference compared with unwell infants (0.28, 0.24 and 
0.28 g/day higher in healthy infants, respectively), while the average dose of TAG196 (13:0_/15:0/_14:0), TAG181 
TAG(14:1_14:1_16:0) and TAG201(12:0_/13:0/_15:1) were higher in unwell infants with the biggest differences 
(all 0.01 g/day higher in unwell infants), although not statistically significant. No relationships were identified 
between dose and maternal BMI, age or parity. The infant dose for all TAGs and 95% confidence intervals are 
listed in Supplementary Table 5.
Discussion
Human milk lipids are essential to the infant and are involved in not only nutrition and growth, but health and 
developmental outcomes21. In this study we have identified 205 HM TAGs, with 98 not previously published. In 
contrast to traditional HM FA methyl ester analysis using GC-FID, untargeted lipidomic analysis was carried out 
with a single phase MTBE lipid extraction, previously validated for HM research and lipidomics, and LC-IM-MS, 
previously used for bovine milk only, in order to analyse the entire intact TAG profile13,14,17.
Figure 3. Human milk triacylglyceride concentration changes with significant differences throughout the 
day (n = 10), (a) TAG28(18:1_/20:1/_20:2), (b) TAG129(14:0_/20:4/_15:1), (c) TAG89(17:1_/16:1/_19:1), (d) 
TAG137(15:0_17:0_17:0).
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The added dimension of ion mobility separation to LC-MS increased the number of TAGs identified in a sin-
gle method to 205, from approximately 80 previously identified at one time (most recently in22 and23, summarised 
prior to 2019 in10). The CCS derived from IM drift time is unique to each TAG composition and conformation 
and was able to be used as an additional identifier, proving valuable for resolving co-eluting species even in 
cases of isomeric TAGs with the same m/z (as shown in Fig. 1b). Other studies have also used IM to increase the 
number of discernible lipid species, in biofluids such as plasma13,15. However, unlike in plasma, we identified 
numerous TAGs containing odd-chain FAs. Human blood was previously thought to have negligible concen-
trations of these TAGs, as they are not endogenously synthesised, however increasing dairy intake may be the 
reason for the increased presence of these odd-chain lipids24. Serum 15:0, for example, may be indicative of total 
dairy lipid intake25. Similarly, the mammary gland can only synthesize short and medium-chain FA, however the 
relationship between maternal diet and FA composition in HM has been demonstrated previously26,27. Previous 
FA research in HM has found odd chain FAs, therefore we expected identification of TAGs containing odd-chain 
FA, such as 17:0 and 19:1, as in TAG13(20:4_/17:0/_22:5) and TAG18(19:1_20:1_20:1)28. Maternal dietary sources 
of fatty acids include foods such as nuts, animal fats, and fish oils, with odd chained FAs primarily derived from 
consumption of dairy milk and meat (Table 3)29. Due to this, future research should include comprehensive die-
tary data collection.
Within the TAG, the FA positioning on the glycerol backbone is critical to its function for the infant. Lipase 
from the infant gut preferentially digests the Sn-1 and Sn-3 FAs, resulting in an Sn-2 monoglyceride, both of 
which function differently30. It is therefore important to identify and quantitate Sn-2 positioned FAs. In the case 
of palmitic acid, research suggests that palmitoylglycerol (monoglyceride) is absorbed more readily in the infant 
gut than the free FA form31. Palmitic acid is the major saturated FA of HM and the majority (70%) of it is thought 
to reside in the Sn-2 position of TAGs32. Due to this positional importance we attempted to use the relative abun-
dance of the fragment ion spectral peaks, allocating the smallest peak as the Sn-2 FA. This reasoning is based 
on the knowledge that the Sn-2 FA fragments least readily, compared to the Sn-1 and Sn-3 FAs on the glycerol 
backbone, resulting in product ions of lower abundance12. Due to the limitation of this method, we were only 
able to tentatively identify the Sn-2 position of the 120 triacid TAGs. It is not possible to use peak intensities 
in the case of diacid or monoacid TAGs, due to repeated FAs resulting in larger spectral peaks, even if one was 
located in the Sn-2 position. Furthermore, the large number of lipids present meant there was overlapping of 
spectral peaks, potentially affecting interpretation, despite the ability of IM to further separate molecular ions. 
Due to these issues, our findings could not support the existing research that 16:0 is primarily in the Sn-2 position 
and this method did not allow elucidation of the Sn-2 FAs with confidence, as is likely in all complex biological 
fluids32,33. Methods capable of better revealing the Sn-2 positioning of TAG FAs, such as collision-induced and 
ozone-induced dissociation, are promising but are unfortunately not commercially available34.
Although we were able to identify TAGs not previously reported, there were some HM TAGs existing in the lit-
erature that were not identified. Of particular interest, these include TAGs with FA compositions (14:0/22:6/22:6), 
Figure 4. The average daily dose of human milk triacylglycerides containing (a) 16:0, (b) 12:0 and (c) 18:2 fatty 
acids delivered to healthy and unwell infants (n = 10).
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(18:1/22:6/22:6) and (18:2/24:0/22:6), and multiple other DHA-containing (22:6) TAGs not identified in this 
study35. In fact, we only identified 8 DHA-containing TAGs in this study. This may be due to the sampling limita-
tion of this small but comprehensive cohort, in which we only compared samples at 3 months post-partum. It is 
possible that certain TAGs, such as those containing DHA, are found in higher concentrations earlier in lactation 
in order to facilitate early neural and retinal development36. It is most likely that this is a result of diet, and that 
the women in our cohort ate less fish than those in previously published studies. Overall DHA intake correlates 
highest with HM DHA content, with fish being the primary dietary origin of DHA FAs37. Despite the knowledge 
that maternal diet may influence HM FAs, lipogenesis in the mammary gland is not well understood. TAG syn-
thesis utilises glycerol and fatty acids obtained via de novo synthesis and from maternal blood, and is thought to 
be different to that occurring in other organs38. This is an area that requires further molecular research in order 
to enhance our understanding.
Although small, the cohort used in this study was found to be representative of a healthy exclusively breast-
feeding population, and consistent with existing knowledge. The range of milk volume productions and therefore 
infant intake among these women (543–894 mL/day) was above that required for a healthy infant to thrive, and 
all infants were trending along their respective growth curves appropriately. Daily HM intake was higher in male 
infants than in female infants, as has previously been published16. Total lipid concentrations increased through a 
feed, as expected, due to both the draining of the breast and the mechanism by which more milk fat globules are 
released as the feed proceeds4,39. Interestingly, the total daily lipid intake did not differ between male and female 
infants, being offset by a higher volume but lower concentration in males, compared to a higher concentration 
and lower volume in females16,40. HM volume has been indicated as the driving factor for infant growth, but dose 
may be the main influence for infant development41. Regardless of sex, we did find the total daily lipid intake 
was higher in unwell infants than in healthy infants, a possible response to protect the mother and/or support 
the infant immune system. The anti-bacterial and anti-viral properties of HM lipids have been reported as likely 
coming from resulting FA and monoglycerides from TAG digestion9. Additionally, HM gangliosides may also 
be involved in antibacterial functions, by inhibiting bacterial enterotoxins42. This difference supports ongoing 
insight into the responsive nature of human milk, through interaction by retrograde ductal flow of milk during 
breastfeeding43–45. Future analysis of the TAG profile prior to, during, and following infant illness would better 
indicate the relationship between maternal and infant health, and HM composition.
As with the total lipid content of HM samples, there were significant changes in the concentrations of TAGs 
through the day, through feeds, and between breasts. Significant changes reported, including an increase in the 
concentration of more than 20 TAGs throughout a feed, could not be explained by TAG identity (mass or degree 
of saturation), and are more likely a reflection of the heterogeneity of the breast alveoli and ductal emptying than 
intentional patterns46. Concentration and/or relative abundance of lipids is most commonly investigated in HM 
lipidomic analysis, however in the case of the impact for the mother-infant dyad, dose is a more appropriate 
measure to investigate.
The infant daily dose of each TAG was vastly different between infants with up to 266% differences for some 
TAGs), despite all infants following appropriate growth trajectories and meeting developmental milestones. This 
was not unexpected as HM is a rich biofluid, specific and unique to the infant, but also influenced by maternal 
diet47–49. In particular, DHA and AA are FAs of great interest in HM research, due to their proposed role in infant 
cognitive function and visual acuity, yet we did not identify any relationships between DHA- and AA-containing 
TAGs and infant head circumference or developmental milestones50. Although crude, head circumference 
correlates with brain volume to give the simplest measure of brain development, along with developmental 
milestone achievements, but with a sample size of 10 healthy infants we are limited in what we can identify51. 
Eicosapentaenoic acid (20:5), myristic acid (14:0) and oleic acid (18:1) have recently been suggested as indicators 
of infant growth in pre-term infants52. These FAs were predicted to be present in higher dose, based on hypothet-
ical volumes (not measured intake), in faster growing infants, yet we saw no relationship between infant growth 
percentiles (weight and length) and the infant dose of eicosapentaenoic, myristic and oleic acid from TAGs. 
This may be because our infants were born term, and it is known that preterm infants have different nutritional 
requirements than term infants53. All palmitic acid (16:0), lauric acid (12:0) and linoleic acid (18:2) - containing 
TAGs were found in higher dose in healthy infants in comparison to unwell infants, suggesting their protective 
function in HM. Previous studies have indicated relationships between these FAs and health, although one study 
reported higher total palmitic acid in unwell infants7. The suggested roles of TAGs are currently limited to existing 
Food Fatty Acids
Vegetable oil 15:1, 16:1, 17:1, 18:1, 18:3
Butter 14:0, 16:0, 17:0, 18:0, 18:2
Salmon 18:4, 20:5, 22:2, 22:5, 22:6
Beef 14:0, 15:0, 20:2, 22:0, 22:4
Tofu 12:0, 14:0, 18:1, 18:2, 18:3
Eggs 16:0, 18:0, 18:2, 20:3, 20:4
Peanuts 16:0, 18:0, 18:2, 20:0, 22:1
Avocado 16:0, 16:1, 18:0, 18:2, 20:1
Bovine milk 12:0, 13:0, 14:1, 17:0, 19:0
Table 3. Examples of the origin of fatty acids in maternal diet. Data compiled from Australian Food 
Composition database29
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knowledge of the FAs that TAGs deliver to the infant, however we did report some differences in TAGs in infants 
who were healthy compared to those who were unwell. TAG93(17:0_/13:0/_22:1), TAG193(12:0_12:0_18:3), 
and TAG199(12:0_14:1_14:1) were found in higher dose in healthy infants, potentially contributing to the func-
tion of HM in preventing infant illness53. In contrast, TAG181(14:1_14:1_16:0), TAG196(13:0_/15:0/_14:0). and 
TAG201(12:0_/13:0/_15:1) were all found in higher dose in the unwell infants, suggesting a malleable responsive 
behaviour of HM, by way of retrograde milk flow43–45. The likely reason we did not identify previously reported 
correlations between infant outcomes, or maternal factors, and the TAG profile is likely due to the sample size of 
this cohort (n = 10). One aspect for future consideration is that the FAs with implications in infant health may 
not come from TAGs. Due to the presence of many other lipid types it is entirely possible that certain FAs, such 
as DHA and AA, originate from other such species as sphingomyelin, from which they are incorporated to the 
infant brain, for example54.
In summary, this LC-IM-MS method allowed further investigation of the lipid profile of HM and identified 
novel lipids not previously published in HM. In particular, many of these novel TAGs contained odd-chained 
FAs, likely originating from maternal diet. In this small cohort we demonstrated that the dose of some TAGs was 
different for healthy infants compared to unwell infants. More extensive investigation of these HM TAGs, and 
other lipid types is indicated, especially in relation to infant dosage and infant outcomes. A deeper understanding 
of these lipids gives rise to the possibility of guiding maternal nutritional guidelines for optimal infant outcomes.
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